A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)
Clinical trial NCT01229267 · COMPLETED
Trial details
- NCT number
- NCT01229267
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-30
- Primary completion
- 2015-12-23
- Enrollment
- 1257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.